Company intelligence / Profile preview
CBRA
Aurora, Colorado, United Statescerebraltherapeutics.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Cerebral Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for refractory neurological diseases. The company utilizes a proprietary implanted infusion system to deliver medications directly into the fluid-filled ventricles of the brain, bypassing the blood-brain barrier. This targeted delivery approach aims to increase efficacy while minimizing systemic side effects. Their lead program, CT-010, is a proprietary formulation of valproate sodium currently being evaluated for the treatment of medically refractory epilepsy.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Medtronic
Beyond the preview
Go deeper on CBRA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CBRA.